Skip to main content
Log in

Die Proktokolektomie bei Colitis ulcerosa

Ist ein mehrzeitiges Vorgehen bei Immunsuppression sinnvoll?

Proctocolectomy in ulcerative colitis

Is a multistep procedure in cases of immunosuppression advisable?

  • Klinische Studien
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

Einleitung

Die Koloproktomukosektomie (CPM) gilt als Verfahren der Wahl für die chirurgische Therapie der Colitis ulcerosa (CU). Bei ausgeprägter Immunsuppression (IS) wird dabei häufig ein dreizeitiges (3Z) Vorgehen gewählt, bei dem eine subtotale Kolektomie der ileoanalen Pouchanlage (IPAA) und abschließenden Ileostomarückverlagerung vorangestellt wird. Im Vergleich zum zweizeitigen (2Z) Vorgehen wird dadurch eine Reduktion der perioperativen Komplikationen erwartet, allerdings ist ein zusätzlicher stationärer Aufenthalt und operativer Eingriff erforderlich. Ziel der hier vorliegenden Studie war es, die beiden Vorgehensweisen im Hinblick auf das klinische Outcome nach IPAA zu vergleichen, um die tatsächliche Effektivität dieser beiden Konzepte überprüfen zu können.

Patienten und Methoden

Zwischen 1997 und 2010 wurden insgesamt 225 Patienten mit IPAA operiert und einem 2Z oder 3Z Verfahren unterzogen. Zur Erfassung des klinischen Outcomes wurde der operative Schritt der Pouchanlage und IPAA gewertet. Die Datenerhebung erfolgte im Rahmen einer prospektiven Studiendokumentation.

Ergebnisse

Von 225 Patienten mit CPM mussten 66 aufgrund einer anderen Diagnose als CU (FAP, Colitis indeterminata, Morbus Crohn) sowie Patienten mit definitiver ILS-Anlage ohne Möglichkeit oder Wunsch einer IPAA (n = 54) ausgeschlossen werden. Untersucht wurden 71 Patienten mit einem 2Z (w = 30, m = 41) und 34 Patienten mit einem 3Z Vorgehen (w = 21, m = 13). Das 3Z Vorgehen wies im Vergleich zum 2Z eine kürzere Operationszeit (246 vs. 296 min; p < 0,05), kürzere Liegedauer (15,5 vs. 24,6 Tage; p < 0,05), kürzeren Intensivaufenthalt (3,3 vs. 7,2 Tage; p < 0,05) und weniger Majorkomplikationen auf (5,9 % vs. 22,5 %; p = 0,035). Patienten mit 3Z Vorgehen zeigten einen höheren BMI (26,2 vs. 23,1 kg/m2; p < 0,05) und nahmen weniger IS ein (10 % vs. 62 %; p < 0,05).

Schlussfolgerung

Die Entscheidung zu einem 3Z Vorgehen bei CU und ausgeprägter IS ist sinnvoll und gerechtfertigt. Durch dieses Vorgehen werden die Immunsuppression sowie deren Einfluss auf die perioperative Morbidität reduziert. Somit kann die IPAA mit kürzerer Operationsdauer, kürzerer Liegedauer und weniger Majorkomplikationen durchgeführt werden.

Abstract

Background

The coloproctomucosectomy (CPM) is the procedure of the choice for the surgical treatment of ulcerative colitis (UC). In cases with pronounced immunosuppression (IS), a 3-step (3S) procedure [i.e., subtotal colectomy and ileal pouch-anal anastomosis (IPAA) and finally ileostomy reconstruction] is often selected. Fewer perioperative complications can be expected compared to the 2-step (2S) procedure; however, an additional in-hospital stay and surgical intervention are necessary. The aim of the present study was to compare both approaches using the clinical outcome of our patients undergoing IPAA to determine efficacy of these two concepts.

Patients and methods

From 1997–2010, a total of 225 patients were operated using a 2S or 3S IPAA procedure. Clinical outcomes were evaluated based on the number of surgical steps for the ileoanal pouch procedure and IPAA. The survey was performed within the scope of prospective study.

Results

Of the 225 patients with CPM, 66 were excluded due to a diagnosis other than UC (familial adenomatous polyposis, indeterminate colitis, Crohn’s disease) and patients with permanent ILS procedures without the possibility or wish for an IPAA (n =  54). Included were 71 patients with 2S (w = 30, m = 41) and 34 patients with 3S procedures (w = 21, m = 13). Compared to the 2S procedure, the 3S procedure was shown to have shorter operation times (246 versus 296 min; p  = 0.05), shorter hospital stays (15.5 versus 24.6 days; p = 0.05), shorter intensive care unit stays (3.3 versus 7.2 days; p = 0.05), and fewer major complications (5.9 % versus 22.5 %; p = 0.035). Patients with 3S procedures had a higher BMI (26.2 versus 23.1 kg/m²; p = 0.05) and fewer required IS (10 % vs. 62 %; p < 0.05).

Conclusion

The decision for a 3S procedure in UC and pronounced IS is advisable and justified. Using a 3S procedure, immunosuppression and its influence on perioperative morbidity are thus reduced. The IPAA can be performed with shorter operation times, shorter hospital stays and fewer major complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Günther U, Kusch D, Heller F et al (2011) Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis. http://www.ncbi.nlm.nih.gov/pubmed/21279369 (Internet)

  2. Travis SPL, Stange EF, Lémann M et al (2008) European evidence-based Consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2:24–62

    Article  PubMed  CAS  Google Scholar 

  3. Siegmund B (2009) Targeted therapies in inflammatory bowel disease. Dig Dis 27:465–469

    Article  PubMed  Google Scholar 

  4. Ikeuchi H, Uchino M, Matsuoka H et al (2010) Surgery for ulcerative colitis in 1000 patients. Int J Colorectal Dis 25:959–965

    Article  PubMed  Google Scholar 

  5. Courtney ED, Brennan M, Noble-Jamieson G et al (2010) Laparoscopic adult colorectal surgeon and adolescents with inflammatory bowel disease: a safe combination? Int J Colorectal Dis

  6. Somashekar U, Gupta S, Soin A, Nundy S (2010) Functional outcome and quality of life following restorative proctocolectomy for ulcerative colitis in Indians. Int J Colorectal Dis 25:967–973

    Article  PubMed  Google Scholar 

  7. Selvasekar CR, Cima RR, Larson DW et al (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204:956–962 (discussion 962–963)

    Article  PubMed  Google Scholar 

  8. Canedo J, Pinto RA, Regadas S et al (2010) Laparoscopic surgery for inflammatory bowel disease: does weight matter? Surg Endosc 24:1274–1279

    Article  PubMed  Google Scholar 

  9. Metcalf AM (2007) Elective and emergent operative management of ulcerative colitis. Surg Clin North Am 87:633–641

    Article  PubMed  Google Scholar 

  10. Diamond IR, Gerstle JT, Kim PCW, Langer JC (2010) Outcomes after laparoscopic surgery in children with inflammatory bowel disease. Surg Endosc. http://www.ncbi.nlm.nih.gov/pubmed/20396907 (Internet)

  11. López-Rosales F, González-Contreras Q, Muro LJ et al (2007) Laparoscopic total proctocolectomy with ileal pouch anal anastomosis for ulcerative colitis and familial adenomatous polyposis: initial experience in Mexico. Surg Endosc 21:2304–2307

    Article  PubMed  Google Scholar 

  12. Böhm G, O’Dwyer ST (2007) The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Int J Colorectal Dis 22:277–282

    Article  PubMed  Google Scholar 

  13. Andersson P, Söderholm JD (2009) Surgery in ulcerative colitis: indication and timing. Dig Dis 27:335–340

    Article  PubMed  Google Scholar 

  14. Dinnewitzer AJ, Wexner SD, Baig MK et al (2006) Timing of restorative proctectomy following subtotal colectomy in patients with inflammatory bowel disease. Colorectal Dis 8:278–282

    Article  PubMed  CAS  Google Scholar 

  15. Cima RR (2010) Timing and indications for colectomy in chronic ulcerative colitis: surgical consideration. Dig Dis 28:501–507

    Article  PubMed  Google Scholar 

  16. Galandiuk S, Pemberton JH, Tsao J et al (1991) Delayed ileal pouch-anal anastomosis. complications and functional results. Dis Colon Rectum 34:755–758

    Article  PubMed  CAS  Google Scholar 

  17. McAllister I, Sagar PM, Brayshaw I et al (2009) Laparoscopic restorative proctocolectomy with and without previous subtotal colectomy. Colorectal Dis 11:296–301

    Article  PubMed  CAS  Google Scholar 

  18. Davies M, Hawley PR (2007) Ten years experience of one-stage restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis 22:1255–1260

    Article  PubMed  CAS  Google Scholar 

  19. Penna C, Daude F, Parc R et al (1993) Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 36:343–348

    Article  PubMed  CAS  Google Scholar 

  20. Rizzo G, Armuzzi A, Pugliese D et al (2011) Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. Int J Colorectal Dis. http://www.ncbi.nlm.nih.gov/pubmed/21594668 (Internet)

  21. Heuschen UA, Hinz U, Allemeyer EH et al (2001) One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg 234:788–794

    Article  PubMed  CAS  Google Scholar 

  22. Ferrante M, D’Hoore A, Vermeire S et al (2009) Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 15:1062–1070

    Article  PubMed  CAS  Google Scholar 

  23. Indar AA, Young-Fadok TM, Heppell J, Efron JE (2009) Effect of perioperative immunosuppressive medication on early outcome in Crohn’s disease patients. World J Surg 33:1049–1052

    Article  PubMed  Google Scholar 

  24. Zmora O, Khaikin M, Pishori T et al (2007) Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives? Int J Colorectal Dis 22:289–292

    Article  PubMed  Google Scholar 

  25. Kunitake H, Hodin R, Shellito PC et al (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12:1730–1736 (discussion 1736–1737)

    Article  PubMed  Google Scholar 

  26. Markel TA, Lou DC, Pfefferkorn M et al (2008) Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 144:540–545 (discussion 545–547+)

    Article  PubMed  Google Scholar 

  27. El-Hussuna A, Andersen J, Bisgaard R et al (2012) Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn’s disease. Scand J Gastroenterol 47(6):662–668

    Article  PubMed  CAS  Google Scholar 

  28. Mor IJ, Vogel JD, Luz Moreira A da et al (2008) Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 51:1202–1207 (discussion 1207)

    Article  PubMed  CAS  Google Scholar 

  29. Scarpa M, Mescoli C, Rugge M et al (2009) Restorative proctocolectomy for inflammatory bowel disease: the Padova prognostic score for colitis in predicting long-term outcome and quality of life. Int J Colorectal Dis 24:1049–1057

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Seifarth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seifarth, C., Gröne, J., Slavova, N. et al. Die Proktokolektomie bei Colitis ulcerosa. Chirurg 84, 802–808 (2013). https://doi.org/10.1007/s00104-013-2552-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-013-2552-6

Schlüsselwörter

Keywords

Navigation